Pradžia › Insulino rezistencija › Kalifornija
Insulino rezistencija klinikiniai tyrimai Kalifornija
11 tyrimai dėl Insulino rezistencija ieško dalyvių vietose Kalifornija.
Miestai Kalifornija
Oficialus tyrimo tekstas (anglų kalba)
Gauging Outcomes of Total Milk Ingestion on Lipid and gControl
- UCSF Medical Center at Parnassus, San Francisco
Renkami dalyviaiLaukiami sveiki savanoriai
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-10-02 · NCT07087184Type 1 Diabetes Extension Study
- UCSF School of Medicine, San Francisco
- Stanford University, Stanford
Renkami dalyviaiStebimasis tyrimas
Amžius nuo 8 iki 35 · Visoms lytims · Atnaujinta 2026-09-18 · NCT02734277INHALE-1st: Afrezza® For Youth With Newly-Diagnosed Type 1 Diabetes
- Children's Hospital Los Angeles, Los Angeles
- University of California San Francisco, San Francisco
Renkami dalyviai2 fazė
Amžius nuo 6 iki 17 · Visoms lytims · Atnaujinta 2026-08-13 · NCT07224321DECIDE: A Comparative Effectiveness Trial of Metformin Versus Insulin for the Treatment of Gestational Diabetes
- Cedars Sinai Medical Center, Los Angeles
- University of California San Francisco, San Francisco
Renkami dalyviai4 fazė
Amžius 18 ir vyresni · Moterims · Atnaujinta 2026-06-25 · NCT06445946Sodium Bicarbonate and Mitochondrial Energetics in Persons With CKD
- University of California Davis Health, Sacramento
Renkami dalyviai2 fazė
Amžius nuo 21 iki 85 · Visoms lytims · Atnaujinta 2026-05-06 · NCT04984226A Single Bolus, 12-hour Euglycemic Clamp Study of the Safety, Pharmacokinetics (PK) and Glucodynamics (GD) of Intraperitoneal (IP) Portal Insulin U-500
- ProSciento, Inc., Chula Vista
Renkami dalyviai1 fazė
Amžius nuo 18 iki 60 · Visoms lytims · Atnaujinta 2026-04-28 · NCT07341373Evexomostat Plus PI3K or AKT Inhibitor and Fulvestrant in Patients With a PI3K Alteration and HR+/Her2- Breast Cancer
- Loma Linda University Cancer Center, Loma Linda
- Hoag Memorial Hospital Presbyterian, Newport
- SHARP Healthcare, San Diego
Renkami dalyviai1/2 fazė
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-04-22 · NCT05455619Normal-weight Diabetes: Adipocyte-directed Therapy With Pioglitazone or Tirzepatide
- Stanford University, Palo Alto
- Stanford University, Clinical and Translational Research Unit (CTRU), Stanford
Renkami dalyviai4 fazėLaukiami sveiki savanoriai
Amžius nuo 30 iki 70 · Visoms lytims · Atnaujinta 2026-04-20 · NCT06657209Effects of Sabroxy® Supplementation on Insulin Resistance and Cognitive Function in Adults With Mild Cognitive Impairment and Insulin Resistance
- San Francisco Research Institute, San Francisco
Renkami dalyviaiLaukiami sveiki savanoriai
Amžius nuo 40 iki 80 · Visoms lytims · Atnaujinta 2026-01-28 · NCT07220694Obesity, Insulin Resistance, and PASC: Persistent SARS-CoV-2
- Stanford Health, Palo Alto
Renkami dalyviaiLaukiami sveiki savanoriai
Amžius nuo 18 iki 80 · Visoms lytims · Atnaujinta 2024-12-04 · NCT05833217Longitudinal Multi-Omic Profiles to Reveal Mechanisms of Obesity-Mediated Insulin Resistance
- Stanford University, Stanford
Renkami dalyviaiLaukiami sveiki savanoriai
Amžius nuo 35 iki 65 · Visoms lytims · Atnaujinta 2024-12-04 · NCT05165706Iš ClinicalTrials.gov, duomenys gauti 2026-10-05. Kiekvienas tyrimas nustato savo tinkamumo kriterijus; tyrimo komanda sprendžia, kas gali dalyvauti.